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ABSTRACT: Developing animals respond to variation in their habitats by alter-
ing their rates of development and/or their morphologies (i.e., they exhibit phe-
notypic plasticity). In vertebrates, one mechanism by which plasticity is
expressed is through activation of the neuroendocrine system, which transduc-
es environmental information into a physiological response. Recent findings of
ours with amphibians and of others with mammals show that the primary ver-
tebrate stress neuropeptide, corticotropin-releasing hormone (CRH), is essen-
tial for adaptive developmental responses to environmental stress. For
instance, CRH-dependent mechanisms cause accelerated metamorphosis in re-
sponse to pond-drying in some amphibian species, and intrauterine fetal stress
syndromes in humans precipitate preterm birth. CRH may be a phylogeneti-
cally ancient developmental signaling molecule that allows developing organ-
isms to escape deleterious changes in their larval/fetal habitat. The response to
CRH is mediated by at least two different receptor subtypes and may also be
modulated by a secreted binding protein.
INTRODUCTION
Embryonic development tends to be buffered against unpredictable environmen-
tal effects.1 By contrast, postembryonic development is strongly influenced by the
external environment (i.e., animals exhibit phenotypic plasticity). The term pheno-
typic plasticity refers to the modification of developmental pathways in response to
environmental cues.2 If a variable phenotype confers a selective advantage over a
fixed phenotype, then the plasticity is considered adaptive. Adaptive phenotypic
plasticity may allow developing organisms to respond to deleterious (i.e., stressful)
changes in their habitat3 and may be an important mechanism in speciation.4
Amphibian tadpoles show strong responses to environmental signals, both by ex-
pressing multiple, discontinuous phenotypes (i.e., polyphenism5) and by exhibiting
continuous variation in the timing of developmental events (i.e., plasticity in the tim-
ing of metamorphosis3,5). While the timing of metamorphosis is determined by both
genetic and environmental factors, alterations in the rates of growth and develop-
ment ultimately depend upon the activity of several endocrine systems. Because of
the dramatic phenotypic plasticity exhibited by amphibians and the importance of
hormonal control, amphibians make excellent models for understanding the ecolog-
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ical factors that influence development, and the neuroendocrine mechanisms that
mediate the response of the organism to a changing environment. This review focus-
es on the role that the neuroendocrine stress axis plays in mediating responses of de-
veloping animals, with particular emphasis on amphibians, to environmental stress.
HORMONAL CONTROL OF AMPHIBIAN METAMORPHOSIS
 Gudernatsch6 provided the first evidence that a substance produced by the thy-
roid gland could influence tadpole metamorphosis. He discovered that feeding tad-
poles horse thyroid extract caused precocious metamorphosis. Following
Gudernatsch’s discovery, many investigators have examined the role of the thyroid
gland in amphibian tadpoles, and now the consensus view is that thyroid hormone
(TH) is the primary morphogen controlling amphibian metamorphosis.7 While TH
is essential for metamorphosis, the coordinated functioning of multiple interacting
endocrine systems is required for normal development.8 For example, corticoster-
oids (CORT)8 have been implicated in the positive control of metamorphosis
through synergy with TH. It is noteworthy that these two hormones have similar
mechanisms of action (receptors are ligand-activated transcription factors) and their
production may be controlled by common neural pathways in tadpoles8,9 (see be-
low). In addition to hormonal effectors of metamorphosis, the pituitary gland pro-
duces the protein hormone prolactin (PRL), which may serve to inhibit the actions
of TH.9
An intact hypothalamus and pituitary portal circulation are essential for meta-
morphosis.9 The hypothalamus produces releasing and release-inhibiting hormones
that are essential for regulating pituitary secretion of thyrotropin (TSH), which stim-
ulates TH production by the thyroid glands, adrenocorticotropin (ACTH), which
stimulates CORT secretion by the interrenal glands, and prolactin (PRL). In mam-
mals the principal stimulatory hypothalamic regulator of TSH secretion is the tri-
peptide amide thyrotropin-releasing hormone (TRH). TRH stimulates TSH in adult
ectotherms (frogs and turtles),10 but,the stimulatory action of TRH on TSH secretion
develops after metamorphic climax in amphibians,11,12 and the bulk of evidence sug-
gests that TRH does not influence TSH release in tadpoles.9 The role that this mol-
ecule plays during metamorphosis may be to control PRL release, although this
possibility has yet to be tested directly.9
CORTICOTROPIN-RELEASING HORMONE IS
A THYROTROPIN-RELEASING FACTOR
Corticotropin-releasing hormone (CRH) is a 41-amino-acid straight-chain
polypeptide that was first isolated for its ability to stimulate ACTH secretion in
mammals13; CRH also stimulates ACTH secretion by frog pituitaries.14 The regula-
tion of ACTH secretion by CRH is commonly considered to be the primary hypo-
physiotropic role for this neuropeptide.15 The vertebrate CRH family of peptides is
composed of at least two functionally distinct paralogous lineages. CRH molecules
have been isolated from the brains of representatives of most vertebrate classes and
appear homologous. By contrast with CRH, the phylogeny of the paralogous lineage
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(or lineages?) sauvagine-urotensin I-urocortin awaits clarification. Urotensin I, a 40-
amino-acid peptide, was first isolated from the caudal neurosecretory organ (urophy-
sis) of the common sucker, Catostomus commersoni16; sauvagine, a 40-amino-acid
peptide, was isolated from the skin of the frog Phyllomedusa sauvagei17; and, most
recently, urocortin, a 40-amino-acid peptide, was cloned from rodent and human
brain.18 The major role for CRH appears to be as a hypophysiotropin, while the re-
lated peptides sauvagine, urotensin I, and urocortin may play roles in the central ner-
vous system and the periphery. The wide distribution and region-specific expression
of CRH-like peptides suggests that these molecules subserve different functions
within the brain and the hypothalamo-hypophyseal axis. In mammals, the actions of
CRH peptides, in addition to their hypophysiotropic role, include control of appetite,
behavioral responses to stress (arousal, escape), and modulation of immune respons-
es, among others.15
While screening for neuropeptides with TSH-releasing factor (TRF) activity in
nonmammalian vertebrates, we discovered that CRH-like peptides are potent TSH
secretagogues in amphibians and reptiles.19,20 CRH has since been shown to stimu-
late the thyroid axis in a fish, several amphibians, a reptile, and a bird. Injections of
CRH cause elevations in whole-body TH levels in tadpoles21,22,23 and plasma TH
levels in the chick embryo24 and the frog, Rana ridibunda.25 Tissue culture studies
using pituitaries from representatives of each nonmammalian vertebrate class have
shown that the stimulation of TSH release by CRH occurs through a direct action on
the anterior pituitary. In species where a specific TSH radioimmunoassay is not yet
available, the release of TSH was monitored by bloassay (amphibians11,19,26) or by
a subtractive method using specific RIAs for the gonadotropin beta subunits and the
alpha subunit (chicken25,27). Specific radloimmunoassays for TSH in the salmon and
turtle have verified that the thyrotropic activity released in response to CRH is au-
thentic TSH (turtle20; salmon28). It is highly likely that CRH stimulates the release
of authentic TSH in amphibians. This conclusion is based upon the observation that
CRH induces the rapid release of thyrotropic activity by tadpole and adult frog pitu-
itaries cultured in vitro;11,19,26 (a specific amphibian TSH RIA is not yet available).
Furthermore, Xenopus tadpole pituitaries cultured in the presence of CRH exhibit a
marked increase in the secretion of a protein with TSH immunoreactivity (deter-
mined by Western blot using anti-human TSHβ serum which crossreacts with frog
TSH; unpublished results). Significantly, while CRH is a potent TRF on cultured
salmon pituitaries, the tripeptide TRH is without activity in controlling TSH re-
lease.28 Thus, CRH is a potent TRF in representatives of all nonmammalian verte-
brates that have been studied. A primitive role for CRH (and a role maintained in
perhaps the majority of extant vertebrate species) may have been to regulate both the
thyroid and the interrenal (adrenal) axes. Whether CRH acts directly on thyrotropes
via a specific CRH receptor is currently unknown. It is also possible that CRH stim-
ulates corticotropes to release a paracrine-acting factor with TSH-releasing activity.
THE CRH RECEPTORS AND BINDING PROTEIN ARE
EVOLUTIONARILY CONSERVED
In mammals, four distinct CRH receptors and one secreted binding protein
(CRHBP) have been identified. The receptors appear homologous, each being a sev-
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en-transmembrane domain G protein-linked receptor, and each transducing extracel-
lular signals by stimulating intracellular cAMP production.13 The receptors exhibit
differential rank-order affinities for CRH peptides and tissue-specific patterns of ex-
pression. The CRHR1 is a 415-amino-acid protein that does not discriminate among
CRH-like peptides (i.e., it possesses high affinity for all). CRHR1 is expressed in the
pituitary and in neocortical, cerebellar, and sensory relay structures in the brain. The
CRHR2, which is 70% homologous to CRHR1, has at least three splicing variants
(CRHR2α–411 a.a.; CRHR2β–431 a.a.; CRHR2γ–397 a.a.), each possessing signifi-
cantly higher affinity for urocortin, SV, and UI than for CRHs. CRHR2 expression is
localized to the lateral septal nuclei and regions of the hypothalamus; within the hy-
pothalamus this receptor could play an important role in CRH autoregulation.13
Similar receptor proteins exist in the frog Xenopus laevis, although there is no ev-
idence for splice variants of the CRHR2.
29 The Xenopus receptors exhibit similar
rank-order affinities for different CRH-like peptides as their mammalian counter-
parts, with the exception that xCRHR1 exhibits low affinity for SV in contrast with
mammalian CRHR1.
29 As in mammals, CRHR1 is expressed in the adult Xenopus
pituitary, while CRHR2 is not.
29 However, nothing is yet known of the tissue distri-
bution, developmental expression, or hormonal regulation of the CRHRs in
amphibians.
Recent demonstrations of the presence of a secreted binding protein for CRH
(CRHBP)30 suggests another important site for modulation of CRH activity. This
322-amino-acid protein is expressed in multiple tissues in mammalian species, in-
cluding the liver, brain, and pituitary gland. CRHBP circulates in the blood in hu-
mans, but not in rats, which may be explained by the lack of expression in rat liver.
Recently, the homologous Xenopus CRHBP was cloned as a T3-regulated gene from
tadpole tail31 and we have shown that this gene is expressed in brain (Valverde and
Denver, unpublished material). The role that this protein plays in modulating CRH
action is poorly understood, and comparative studies in species other than mammals
are thus far lacking. Some possible functions include modulation of CRH action by
blocking the bioavailability of CRH or targeting the peptide for clearance, as has
been suggested in human pregnancy.30 Alternatively, the CRHBP could function to
maintain high levels of CRH in the blood or within tissues, thus facilitating the ac-
tion of the peptide. It has been suggested that the upregulation of this protein during
metamorphic climax might serve a negative feedback function by sequestering CRH
and thus modulating its bioavailability.31 The accessibility of the tadpole makes it a
valuable animal model for defining roles for this protein in animal development.
EXOGENOUS CRH INDUCES METAMORPHOSIS
IN AMPHIBIAN LARVAE
Studies from several labs have shown that CRH is capable of accelerating tadpole
metamorphosis. For example, Gancedo and colleagues21 showed that CRH stimu-
lates metamorphosis and elevates whole-body TH content in the ranid frog Rana
perezi. My studies showed that CRH accelerates metamorphosis and elevates whole-
body thyroid hormone in the ranid frog Rana catesbeiana and the pelobatid toad
Scaphiopus hammondii.22,23 CRH also accelerates metamorphosis in the bufonid
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Bufo arenarum (L. Miranda, personal communication) and in the ambystomatid
salamander Ambystoma tigrinum (Boorse and Denver, unpublished observations).
ENDOGENOUS CRH FUNCTIONS AS A PHYSIOLOGICAL MEDIATOR 
OF STRESS-INDUCED METAMORPHOSIS
A role for endogenous CRH in controlling spontaneous metamorphosis was first
suggested by my findings with tadpoles of the bullfrog, Rana catesbeiana, in which
passive immunization with CRH antiserum slowed spontaneous metamorphosis.22
This finding suggests a physiological role for CRH in controlling spontaneous meta-
morphosis. Our ability to alter metamorphic timing in the lab by altering environ-
mental conditions32 has allowed us to test the hypothesis that endogenous CRH
participates in environmentally induced (stress-induced) metamorphosis.23
Probably the most important environmental variable for a tadpole is water avail-
ability, and pond duration can profoundly influence the rate of metamorphosis in
some species.5,23,32 Desert amphibians tend to breed in ephemeral habitats; pools are
sporadically filled by rainfall and then dry at different rates, depending on a combi-
nation of geologic and climatic factors. Because these species exhibit facultative
timing of metamorphosis they are ideal model systems for studying the physiologi-
cal mechanisms of phenotypic plasticity. Our studies in the western spadefoot toad
S. hammondii show that metamorphosis can be accelerated in the laboratory by re-
ducing the water level of the aquaria that the tadpoles are raised in.5,23,32 Further-
more, this developmental response is reversible until metamorphic climax: shifting
tadpoles back to a high water environment restores body mass and decelerates meta-
morphosis (i.e., release from ecological stress32).
As mentioned above, injections of CRH-like peptides accelerated metamorphosis
in the western spadefoot toad, S. hammondii.5,23 Conversely, the developmental ac-
celeration induced by water volume reduction was attenuated by injection of the
CRH receptor antagonist α-helical CRH(9-41)or by passive immunization with anti-
CRH serum. Tadpoles exhibited elevated hypothalamic CRH concentrations at the
time that they first responded (morphologically and endocrinologically) to the water
volume reduction.23 Tadpoles subjected to water volume reduction also exhibited a
precocious elevation in whole-body TH and CORT contents.33 Taken together with
the findings that CRH injections can accelerate metamorphosis in several amphibian
species, these data point to a central role for CRH in controlling stress-induced (and
perhaps also spontaneous) metamorphosis.
CRH MAY BE A PHYLOGENETICALLY ANCIENT
DEVELOPMENTAL SIGNALING MOLECULE
CRH may represent a phylogenetically ancient developmental signaling molecule
that vertebrates use to assess changes in their habitat and to respond accordingly. Re-
cent data in mammalian species including humans show that CRH of fetal and/or
placental origin functions as a timing mechanism regulating the length of the gesta-
tional period and perhaps shortening gestation under situations of fetal stress.34 The
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action of CRH in tadpole metamorphosis suggests that the action of this hormone in
controlling the developmental response of the larva/fetus to environmental stress
arose early in vertebrate evolution.
SUMMARY AND CONCLUSIONS
CRH is a versatile adaptive hormone, promoting survival through maintenance of
homeostasis and beneficial behaviors in response to stressful situations. Our ecolog-
ical and endocrinological studies suggest that tadpoles use special senses to detect a
desiccating habitat and mount a classical neuroendocrine stress response. The CRH
neuron is likely to be an important transducer of the environmental signal into an en-
docrine response leading to accelerated metamorphosis. In tadpoles, the CRH signal
is transduced by at least two receptor subtypes and may be modulated by a secreted
binding protein. Evolutionary conservation of the role of CRH in mediating devel-
opmental plasticity is suggested by recent demonstrations in mammals that CRH of
fetal and/or placental origin determines the length of the gestational period. Further-
more, elevations in fetal CRH under conditions of intrauterine stress may precipitate
preterm birth.
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